Oldest pages
Showing below up to 50 results in range #1,651 to #1,700.
- Venous thromboembolism (10:35, 8 July 2024)
- Gastrointestinal bleeding (10:37, 8 July 2024)
- Deep vein thrombosis (10:38, 8 July 2024)
- Peptic ulcer disease (10:38, 8 July 2024)
- Gastroesophageal reflux disease (10:39, 8 July 2024)
- Inflammatory bowel disease (Crohn disease and ulcerative colitis) (10:39, 8 July 2024)
- Hyperthyroidism and thyrotoxicosis (10:40, 8 July 2024)
- Acute pancreatitis (10:41, 8 July 2024)
- Direct oral anticoagulants (11:33, 8 July 2024)
- Peritonitis (11:54, 8 July 2024)
- Acute abdomen (11:55, 8 July 2024)
- Cholangiocellular carcinoma (11:59, 8 July 2024)
- Pneumonia (12:07, 8 July 2024)
- Blood culture (14:01, 10 July 2024)
- 1. Normal and postmortal pancreas (17:06, 11 July 2024)
- Leg ulcer (20:02, 15 July 2024)
- Peripheral artery disease (20:04, 15 July 2024)
- Chronic venous disorder (20:05, 15 July 2024)
- A5. Leg ulcer (20:05, 15 July 2024)
- A6. Skin diseases caused by human papilloma virus (HPV) (20:08, 15 July 2024)
- Herpes simplex virus infection (20:10, 15 July 2024)
- Human papilloma virus infection (20:10, 15 July 2024)
- A7. Herpes simplex virus (HSV) infections of the skin (20:11, 15 July 2024)
- Herpes zoster (16:48, 17 July 2024)
- Varicella (16:49, 17 July 2024)
- A8. Skin diseases caused by varicella zoster virus (16:50, 17 July 2024)
- Bullous pemphigoid (16:51, 17 July 2024)
- Pemphigus vulgaris (16:51, 17 July 2024)
- Dermatitis herpetiformis (16:52, 17 July 2024)
- Epidermolysis bullosa (16:52, 17 July 2024)
- A9. Autoimmune bullous skin diseases (16:54, 17 July 2024)
- Cutaneous lupus erythematosus (16:56, 17 July 2024)
- Systemic lupus erythematosus (16:58, 17 July 2024)
- A10. Lupus erythematosus and its variants (16:59, 17 July 2024)
- Scleroderma (17:01, 17 July 2024)
- A11. Scleroderma and its variants (17:02, 17 July 2024)
- A12. Malignant melanoma (17:06, 17 July 2024)
- Fungal diseases of the skin and its appendages (17:07, 17 July 2024)
- A13. Fungal diseases of the skin and its appendages (17:08, 17 July 2024)
- Drug allergy (17:12, 17 July 2024)
- Severe cutaneous adverse reactions (17:17, 17 July 2024)
- A14. Drug allergy (17:18, 17 July 2024)
- Urticaria (17:19, 17 July 2024)
- A15. Urticaria (17:19, 17 July 2024)
- Scabies (17:20, 17 July 2024)
- Pediculosis (17:21, 17 July 2024)
- A16. Scabies, pediculosis (17:22, 17 July 2024)
- Naevus (17:24, 17 July 2024)
- A17. Pigmented naevi (17:25, 17 July 2024)
- Cutaneous small vessel vasculitis (17:33, 17 July 2024)